# Chemed Corp (CHE) Stock Analysis: Healthcare Giant with a 34.53% Potential Upside

- Link: https://www.directorstalkinterviews.com/chemed-corp-che-stock-analysis-healthcare-giant-with-a-34-53-potential-upside/4121220604
- Published: 2025-10-13T10:47:19+01:00
- Author: Madison Wilson

Chemed Corp (CHE) is a prominent player in the healthcare sector, specifically within
the medical care facilities industry. Headquartered in Cincinnati, Ohio, the company
operates through two primary segments: VITAS, which provides hospice and palliative
care services, and Roto-Rooter, offering plumbing and related services. With a market
capitalization of $6.27 billion, Chemed has established itself as a significant 
entity in the U.S. healthcare landscape.

Currently trading at $430.02, Chemed’s stock has experienced fluctuations, with 
a 52-week range between $412.30 and $619.21. Despite a recent price change of -1.39,
representing a negligible percentage drop, the stock’s future appears promising 
according to analyst projections.

One of the most striking aspects of Chemed’s financial metrics is the impressive
34.53% potential upside, based on the average target price of $578.50. This optimism
is further supported by the unanimous analyst ratings, with four buy recommendations
and no hold or sell ratings. The target price range set by analysts is between $
550.00 and $595.00, indicating a strong belief in the stock’s potential to rally.

In terms of valuation, Chemed’s forward P/E ratio stands at 16.99, suggesting expectations
of stable earnings growth. The company also boasts a robust return on equity of 
24.14%, a testament to its efficient management and profitable operations. Chemed’s
earnings per share (EPS) is a solid $19.44, which supports its growth narrative 
despite the absence of trailing P/E, PEG, price/book, price/sales, and EV/EBITDA
metrics.

Chemed’s revenue growth of 3.80% reflects a steady expansion, while its free cash
flow of $285 million underscores its financial health and ability to reinvest in
business operations or return value to shareholders. The company’s dividend yield
of 0.56%, combined with a conservative payout ratio of 10.29%, suggests a commitment
to rewarding shareholders while maintaining sufficient capital for growth initiatives.

Technical indicators present a mixed picture. The stock’s 50-day moving average 
is $447.59, and the 200-day moving average is notably higher at $525.25, suggesting
that the stock has been trading below recent historical levels. The Relative Strength
Index (RSI) of 24.67 indicates that the stock is currently in an oversold territory,
which could point to a potential rebound opportunity for investors. However, with
a MACD of -5.81 and a signal line of -3.68, caution is advised as these indicators
suggest bearish momentum.

Chemed Corporation’s dual focus on healthcare services and home maintenance solutions
offers a diversified revenue stream that can appeal to investors seeking stability
in a volatile market. The company’s ability to provide both direct medical services
and essential household solutions positions it uniquely within its sector.

For investors considering adding Chemed Corp to their portfolios, the combination
of strong analyst ratings, potential upside, and robust financial performance makes
it an attractive prospect. However, the technical indicators advise a careful approach,
potentially waiting for signs of momentum reversal before taking a position. As 
with any investment, conducting thorough research and considering personal financial
goals and risk tolerance is essential.

Share on:
